Leap Medical: Subsidiary company's injection of sodium hyaluronate solution obtained NMPA registration approval.

LePu Medical announced that its subsidiary, Sichuan XingTai LePu Medical Technology Co., Ltd., has independently developed an injection-grade hyaluronic acid sodium solution that has received approval from the National Medical Products Administration, with registration number: National Medical Equipment Admission Approval 20253131324. This product belongs to the water light needle category, which effectively solves the problem of skincare products being difficult to absorb through the skin by accurately injecting essential nutrients into the shallow or middle layers of the dermis. This approval further enriches the company's product matrix in the field of dermatology and is expected to have a positive impact on the company's development. However, the sales performance of the new product after its launch may be influenced by various factors, leading to uncertainty about its impact on the company's future performance.